Epidermal growth factor receptor degradation: An alternative view of oncogenic pathways

被引:43
|
作者
Kirisits, Andreas [1 ]
Pils, Dietmar [1 ]
Krainer, Michael [1 ]
机构
[1] Med Univ Vienna, Dept Med 1, Clin Div Oncol, Vienna, Austria
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2007年 / 39卷 / 12期
关键词
EGFR; receptor degradation; ubiquitination; MVB; ESCRT; cancer;
D O I
10.1016/j.biocel.2007.07.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Positive regulation of epidermal growth factor receptor signalling is related to many human malignancies. Besides overexpression and gain of function mutations, the escape from negative regulation through an increase in epidermal growth factor receptor stability has evolved as yet another key factor contributing to enhanced receptor activity. Intensive research over the past years has provided considerable evidence concerning the molecular mechanisms which provide epidermal growth factor receptor degradation. c-Cbl mediated ubiquitination, endocytosis via clathrin-coated pits, endosomal sorting and lysosomal degradation have become well-investigated cornerstones. Recent findings on the interdependency of the endosomal sorting complexes required for transport in multivesicular body sorting, stress the topicality of receptor tyrosine kinase downregulation. Here, we review the degradation pathway of the epidermal growth factor receptor, following the receptor from ligand binding to the lysosome and illustrating different modes of oncogenic deregulation. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2173 / 2182
页数:10
相关论文
共 50 条
  • [21] VAV2 regulates epidermal growth factor receptor endocytosis and degradation
    Thalappilly, S.
    Soubeyran, P.
    Iovanna, J. L.
    Dusetti, N. J.
    ONCOGENE, 2010, 29 (17) : 2528 - 2539
  • [22] The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunate's Activity in Cancer Cells
    Konkimalla, V. Badireenath
    McCubrey, James A.
    Efferth, Thomas
    CURRENT CANCER DRUG TARGETS, 2009, 9 (01) : 72 - 80
  • [23] VAV2 regulates epidermal growth factor receptor endocytosis and degradation
    S Thalappilly
    P Soubeyran
    J L Iovanna
    N J Dusetti
    Oncogene, 2010, 29 : 2528 - 2539
  • [24] Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity
    Feng, F. Y.
    Varambally, S.
    Tomlins, S. A.
    Chun, P. Y.
    Lopez, C. A.
    Li, X.
    Davis, M. A.
    Chinnaiyan, A. M.
    Lawrence, T. S.
    Nyati, M. K.
    ONCOGENE, 2007, 26 (23) : 3431 - 3439
  • [25] Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
    Kaufman, Nichole E. M.
    Dhingra, Simran
    Jois, Seetharama D.
    Vicente, Maria da Graca H.
    MOLECULES, 2021, 26 (04):
  • [26] BB, a novel epidermal growth factor receptor inhibitor
    Wheeler, Deric L.
    Dunn, Emily F.
    CANCER BIOLOGY & THERAPY, 2009, 8 (17) : 1655 - 1657
  • [27] Epidermal growth factor receptor targeting and challenges in glioblastoma
    Thorne, Amy Haseley
    Zanca, Ciro
    Furnari, Frank
    NEURO-ONCOLOGY, 2016, 18 (07) : 914 - 918
  • [28] Overexpression and activation of epidermal growth factor receptor in hemangioblastomas
    Chen, Gregory J.
    Karajannis, Matthias A.
    Newcomb, Elizabeth W.
    Zagzag, David
    JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) : 195 - 200
  • [29] Targeting the epidermal growth factor receptor
    El-Rayes, BF
    LoRusso, PM
    BRITISH JOURNAL OF CANCER, 2004, 91 (03) : 418 - 424
  • [30] Targeting the epidermal growth factor receptor
    B F El-Rayes
    P M LoRusso
    British Journal of Cancer, 2004, 91 : 418 - 424